Properties (48)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Medication
|
| gptkbp:availableIn |
Generic
|
| gptkbp:brand |
gptkb:Pantozol
gptkb:Protonix Pantoloc Tecta |
| gptkbp:chemicalFormula |
C16H15F2N3O4S
|
| gptkbp:clinicalTrials |
Phase III
Long-term management Short-term treatment |
| gptkbp:composedOf |
Sulfonamide chemistry
|
| gptkbp:contraindication |
Severe liver disease
Hypersensitivity to pantoprazole |
| gptkbp:dosageForm |
Tablet
Injection |
| gptkbp:drugInterdiction |
Proton pump inhibitor
|
| gptkbp:endOfLife |
1 hour
|
| gptkbp:formulation |
Enteric-coated tablet
Delayed-release tablet |
| gptkbp:gestationPeriod |
B
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pantoprazole
|
| gptkbp:interactsWith |
Warfarin
Clopidogrel Methotrexate |
| gptkbp:isATypeOf |
102625-70-7
|
| gptkbp:mandates |
Peptic ulcer disease
Helicobacter pylori eradication |
| gptkbp:nutritionalValue |
Hepatic
|
| gptkbp:operates_in |
A02BC02
|
| gptkbp:patentMaintenanceFee |
2000
|
| gptkbp:researchAreas |
Gastroenterology
Pharmacology Drug interactions Chronic gastritis |
| gptkbp:route |
Intravenous
Oral |
| gptkbp:sideEffect |
Diarrhea
Dizziness Nausea Headache Abdominal pain |
| gptkbp:targets |
gptkb:H+/K+_ATPase
|
| gptkbp:triggerType |
Inhibits proton pump in gastric parietal cells
|
| gptkbp:usedFor |
gptkb:Zollinger-Ellison_syndrome
Gastroesophageal reflux disease (GERD) Erosive esophagitis |
| gptkbp:waterManagement |
Renal
|
| gptkbp:yearEstablished |
1979
|